Medford, MA, United States of America

Danielle N Rockwood

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 8.3

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):

Title: The Innovative Contributions of Danielle N Rockwood

Introduction

Danielle N Rockwood is a prominent inventor based in Medford, MA (US), known for her significant contributions to cancer treatment through innovative compounds and compositions. With a total of three patents to her name, she has made strides in the field of oncology, focusing on platinum-based therapies.

Latest Patents

Danielle's latest patents include groundbreaking work on platinum compounds, compositions, and their uses in cancer treatment. One of her notable patents discusses a platinum (IV) complex that features at least one reacting group capable of interacting with a functional group on a protein. Another patent elaborates on compounds and compositions that also utilize a platinum (IV) complex, specifically highlighting the inclusion of carboxylate or carbamate ligands for enhanced therapeutic effects.

Career Highlights

Throughout her career, Danielle has worked with esteemed organizations such as Placon Therapeutics, Inc. and Tarveda Therapeutics, Inc. Her work in these companies has allowed her to develop and refine her innovative approaches to cancer treatment, contributing to the advancement of medical science.

Collaborations

Danielle has collaborated with notable professionals in her field, including Mark T Bilodeau and Rossitza Gueorguieva Alargova. These collaborations have further enriched her research and development efforts, leading to impactful innovations in cancer therapies.

Conclusion

Danielle N Rockwood's contributions to the field of cancer treatment through her innovative patents and collaborations highlight her role as a leading inventor. Her work continues to inspire advancements in oncology and offers hope for improved therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…